HIQA's CEA of Breast Screening: Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not

Value in Health

Volumn 18, Issue 8, 2015, Pages 941-945

  O'Mahony, James F ^a   Normand, Charles ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

average cost effectiveness ratio; consistency; cost effectiveness analysis; incremental cost effectiveness ratio

Indexed keywords

AVERAGE COST EFFECTIVENESS RATIO; BREAST CANCER; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECONOMIC EVALUATION; HEALTH CARE FACILITY; HEALTH INFORMATION AND QUALITY AUTHORITY; INCREMENTAL COST EFFECTIVENESS RATIO; IRELAND; PRIORITY JOURNAL; REVIEW; BREAST NEOPLASMS; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; HUMAN; POLICY; RISK FACTOR; STATISTICAL MODEL;

BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; IRELAND; MODELS, ECONOMETRIC; POLICY; RISK FACTORS;

EID: 84949782284     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2015.08.009     Document Type: Article

References (35)

1. L. Tilson, A. O'Leary, C. Usher, and et al. Pharmacoeconomic evaluation in Ireland Pharmacoeconomics 28 2010 307 322
2. Oireachtas Éireann. Health Act 2007. 2007. Available from: http://www.oireachtas.ie/documents/bills28/acts/2007/a2307.pdf. [Accessed November 18, 2014].
3. Health Information and Quality Authority Health Technology Assessment (HTA) of Surveillance of Women Aged Less Than 50 Years at Elevated Risk of Breast Cancer Health Information and Quality Authority, Dublin, Ireland 2013
4. Health Information and Quality Authority Health Technology Assessment (HTA) of a Population-Based Colorectal Cancer Screening Programme in Ireland Health Information and Quality Authority, Dublin, Ireland 2009
5. G. Karlsson, and M. Johannesson The decision rules of cost-effectiveness analysis Pharmacoeconomics 9 1996 113 120
6. A.M. Gray, P.M. Clarke, J.L. Wolstenholme, and et al. Applied Methods of Cost-Effectiveness Analysis in Healthcare 2011 Oxford University Press Oxford
7. M.C. Weinstein, and W.B. Stason Foundations of cost-effectiveness analysis for health and medical practices N Engl J Med 296 1977 716 721
8. M. Weinstein, and R. Zeckhauser Critical ratios and efficient allocation J Pub Econ 2 1973 147 157
9. A.S. Detsky, and I.G. Naglie A clinician's guide to cost-effectiveness analysis Ann Intern Med 113 1990 147 154
10. M.C. Weinstein Principles of cost-effective resource allocation in health care organizations Int J Technol Assess Health Care 6 1990 93 103
11. J.E. Siegel, M.C. Weinstein, L.B. Russell, and et al. Recommendations for reporting cost-effectiveness analyses Jama 276 1996 1339 1341
12. J.S. Hoch, and C.S. Dewa A clinician's guide to correct cost-effectiveness analysis: think incremental not average Can J Psychiatry 53 2008 267 274
13. Canadian Agency for Drugs and Technologies in Health Guidelines for the Economic Evaluation of Health Technologies: Canada 3rd ed. 2006 Canadian Agency for Drugs and Technologies in Health Ottawa, Canada
14. National Institute for Health and Care Excellence Guide to the Methods of Technology Appraisal 2013 National Institute for Health and Care Excellence, London, England 2013
15. Pharmaceutical Benefits Advisory Committee Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee 2008 Pharmaceutical Benefits Advisory Committee Canberra, Canada
16. PHARMAC Prescription for Pharmacoeconomic Analysis: Methods for Cost-Utility Analysis Pharmaceutical Management Agency, Wellington, England 2012
17. Scottish Medicines Consortium Guidance to Manufacturers for Completion of New Product Assessment Form 2013 Scottish Medicines Consortium Glasgow, Scotland
18. I. Cleemput, M. Neyt, S. van de Sande, and et al. Belgian Guidelines for Economic Evaluations and Budget Impact Analyses Second Edition 2012 Belgian Health Care Knowledge Centre (KCE) Brussels, Belgium
19. Haute Autorité de Santé Choices in Methods for Economic Evaluation Saint-Denis La Plaine, France: Haute Autorité de Santé 2012
20. M.F. Drummond, and A. MacGuire Economic Evaluation in Health Care: Merging Theory with Practice 2001 Oxford University Press Oxford, England
21. M.F. Drummond, B. O'Brien, G.L. Stoddart, and et al. Methods for the Economic Evaluation of Health Care Programmes 2005 Oxford University Press Oxford
22. M.R. Gold, J.E. Siegel, L.B. Russell, and et al. Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York
23. G.W. Torrance, J.E. Siegel, and B.R. Luce Framing and designing the cost-effectiveness analysis M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York
24. A.H. Briggs, M.C. Weinstein, E.A. Fenwick, and et al. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6 Med Decis Making 32 2012 722 732
25. A. Williams Cost-effectiveness analysis: is it ethical? J Med Ethics 18 1992 7 11
26. M.C. Weinstein, G. Torrance, and A. McGuire QALYs: the basics Value Health 12 Suppl. 1 2009 S5 S9
27. J.F. O'Mahony Cost-effectiveness of population-based screening for colorectal cancer Br J Cancer 108 2013 1209
28. S. Byford, and S. Palmer Common errors and controversies in pharmacoeconomic analyses Pharmacoeconomics 13 1998 659 666
29. M. Drummond, and M. Sculpher Common methodological flaws in economic evaluations Med Care 2005 II-5-14
30. S. Birch, and A. Gafni Cost effectiveness/utility analyses: do current decision rules lead us to where we want to be? J Health Econ 11 1992 279 296
31. J. Coast Is economic evaluation in touch with society's health values? BMJ 329 2004 1233
32. E. Elsinga, and F.F. Rutten Economic evaluation in support of national health policy: the case of The Netherlands Soc Sci Med 45 1997 605 620
33. P.J. Neumann, A.B. Rosen, and M.C. Weinstein Medicare and cost-effectiveness analysis N Engl J Med 353 2005 1516
34. M.E. van Velden, J.L. Severens, and A. Novak Economic evaluations of healthcare programmes and decision making Pharmacoeconomics 23 2005 1075 1082
35. I.P. Williams, and S. Bryan Cost-effectiveness analysis and formulary decision making in England: findings from research Soc Sci Med 65 2007 2116 2129